Gorog P, Kovacs I B
Pathopharmacology Unit, The William Harvey Research Institute, London, UK.
J Vasc Res. 1998 May-Jun;35(3):165-9. doi: 10.1159/000025580.
Migration of vascular smooth muscle cells (SMCs) leading to neointimal hyperplasia is an early and cardinal feature of atherogenesis. Migration of rat aortic SMCs from an upper chamber towards a lower one has been studied in a microchemotaxis (Boyden) chamber. Spontaneous migration of SMCs was practically prevented by the presence of endothelium in the lower chamber and was reduced if endothelial cells were substituted with endothelial cell-conditioned medium. Endothelial cells which had been treated with either the inhibitor of protein synthesis cycloheximide or nitric oxide synthesis N(G)-nitro-L-arginine showed no inhibitory effect on SMC migration. Addition of a nitric oxide donor S-nitroso-N-acetylpenicillamine to cell-free medium in the lower chamber prevented SMC migration. Addition of native LDL to endothelial cells had no effect on SMC migration, while (UV light) oxidised LDL completely abolished the inhibitory effect of endothelial cells on SMC migration. It is concluded that via nitric oxide, endothelium exerts a powerful inhibitory effect on SMC migration. This effect of intact endothelium is completely abolished by oxidised LDL applied in a concentration, which is relevant to those measured in plasma of patients with severe coronary artery disease. It is suggested that oxidised LDL may contribute to the pathogenesis of atherogenesis by stimulating migration of SMCs from media to the intima via abolishing the physiological inhibitory effect of normal endothelium.
血管平滑肌细胞(SMC)迁移导致内膜增生是动脉粥样硬化形成的早期主要特征。已在微趋化性(Boyden)小室中研究了大鼠主动脉SMC从上层小室向下层小室的迁移。下层小室中存在内皮细胞实际上可阻止SMC的自发迁移,若用内皮细胞条件培养基替代内皮细胞,则迁移会减少。用蛋白质合成抑制剂环己酰亚胺或一氧化氮合成抑制剂N(G)-硝基-L-精氨酸处理的内皮细胞对SMC迁移无抑制作用。向下层无细胞培养基中添加一氧化氮供体S-亚硝基-N-乙酰青霉胺可阻止SMC迁移。向内皮细胞中添加天然低密度脂蛋白(LDL)对SMC迁移无影响,而(紫外线)氧化型LDL完全消除了内皮细胞对SMC迁移的抑制作用。得出的结论是,内皮细胞通过一氧化氮对SMC迁移发挥强大的抑制作用。完整内皮细胞的这种作用被以与重症冠状动脉疾病患者血浆中测得的浓度相关的浓度应用的氧化型LDL完全消除。提示氧化型LDL可能通过消除正常内皮细胞的生理抑制作用,刺激SMC从血管中膜向内膜迁移,从而促进动脉粥样硬化的发病机制。